Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Rankning i aktier #24646
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Aktiekurs
$3.06
Marknadsvärde
$58.25M
Förändring (1 dag)
-0.65%
Förändring (1 år)
-73.27%
Land
US
Handel Elicio Therapeutics, Inc. (ELTX)

Kategori

Aktiekurshistorik för Elicio Therapeutics, Inc. (ELTX)
Högsta slutkurs: $3.10 den 2026-08-01

Lägsta slutkurs: $5.88 den 2023-11-01
Aktiekurshistorik för Elicio Therapeutics, Inc. från 2023 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$549.19 38.17%
US
$1.05K 58.07%
NL
$148.12 464.91%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH